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Letter to the Editor
DFNB93, a novel locus for autosomal
recessive moderate-to-severe hearing
impairment
To the Editor :
Hearing impairment (HI) is the most common
sensory defect in human (1). The cause of HI
can be environmental or genetic. Approximately
80% of hereditary non-syndromic HI is autosomal
recessive (ARNSHI). Up to now, more than 70
chromosomal loci (known as DFNB) have been
localized for ARNSHI and the responsible genes
have been identified in about 50% of DFNB loci.
As ARNSHI in most cases is pre-lingual, non-
progressive and severe-to-profound, it is often
impossible to distinguish between different
ARNSHI genes based on audiometric data. Thus
far, among all the genes for ARNSHI, only
TECTA (DFNB21 locus) causes moderate-to-
severe HI (2, 3). Because this is a rare and rec-
ognizable phenotype caused by a single gene, it
represents an important guideline for DNA diag-
nostics for ARNSHI.
In this study, we mapped a novel locus for
ARNSHI to chromosome 11q12.3–13.3, found in
an Iranian family with the distinctive audiometric
profile of moderate-to-severe HI. This is the sec-
ond ARNSHI locus to cause a recognizable milder
phenotype. The name DFNB93 was assigned to
this locus by the Human Genome Organization
(HUGO) Nomenclature Committee (4).
Family IR-Sh10, living in an isolated village
in the south of Iran, was ascertained (pedigree
is shown in Fig. 1). The hearing impaired fam-
ily members underwent clinical examinations in
a local clinical center (performed by Dr M.
Hassanzadeh). Air and bone conduction pure-tone
audiometry was performed at frequencies rang-
ing from 250 to 8000 Hz. Genomic DNA was
extracted from EDTA-treated blood from 14 mem-
bers of the family IR-Sh10 (5). Analysis of fluores-
cently labeled PCR-amplified short tandem repeat
polymorphic (STRP) microsatellite markers was
performed on an ABI 3130 DNA sequencer (XL
Genetic Analyzer, ABI) using standard procedures.
Alleles were assigned using GeneMapper v.3.7
software (Applied Biosystem, Foster, CA).
The genome scan analysis was performed using
the Illumina SNP array utilizing 6K SNP Link-
age Panel IVb (Illumina Inc., San Diego, CA).
Linkage analysis was performed by calculating
two-point and multi-point parametric logarithm of
odds (LOD) scores using the Superlink (v.1.6) and
Simwalk (v.2.91) options of EasyLINKAGE plus
(version 5.01beta) (URL: http://sourceforge.net/
projects/easylinkage/), respectively (6, 7). The
physical positions of the STRP and SNP markers
were obtained from the NCBI genome sequence
Build 37.1. Haplotypes were reconstructed via
Simwalk. Mistyping errors were checked and
removed by looking at the Mendelian inconsisten-
cies and double recombinations by Simwalk.
The potential candidate genes in the linked
interval region on chromosome 11q were identi-
fied using the UCSC Genome Build 37.1. A set
of criteria including gene functions, gene expres-
sion patterns, protein interactions and literature
review were used for candidate gene prioritiza-
tion. Data from the Massively Parallel Signature
Sequencing (MPSS) inner ear libraries (8) and
from human inner ear cDNA libraries (9) were also
queried to identify potential candidate DFNB93
genes. In addition, the Endeavour Web-based
software, using motif and blast score and inter-
action with other known HI genes, was also uti-
lized to help prioritizing the candidate genes (10).
DNA sequencing of candidate genes was per-
formed on an ABI 3130 automated sequencer (XL
Genetic Analyzer, ABI) using the big-Dye termi-
nator cycle sequencing kit Version 3.1 (Applied
Biosystem).
All 14 family members, including 4 patients,
were interviewed and underwent clinical exam-
inations. The presence of possible abnormali-
ties present in syndromic forms of deafness
was investigated. There was no obvious clinical
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Fig. 1. Pedigree and haplotypes of the Iranian family IR-Sh10 segregating ARNSHI. A double marriage line denotes consanguinity.
The STRP markers and their relative physical positions (Mb) are shown next to the pedigree. Haplotypes homozygous only in
patients are boxed. The flanking markers D11S1765 (60.68 Mb) and D11S1975 (70.30 Mb), defining a critical interval of 9.62 Mb,
are highlighted with an arrow. (Almost 50 microsatellite markers were run on the candidate region for this family, but only the
genotypes of 17 selected markers are shown in the figure.)
manifestation co-segregating with HI in the study
family, leading to a diagnosis of ARNSHI.
All 4 affected individuals showed a history of
pre-lingual HI. The family patients use a combina-
tion of sign language and oral communication. The
audiometric profile showed that HI is stable, bilat-
eral, symmetric and moderate-to-severe in degree
in all frequencies. The HI is slightly more pro-
nounced in the mid-frequencies, resulting in a flat-
to-shallow U-shaped audiogram. Figure 2 shows
the audiograms of the right ear of all four affected
family members (as the HI was symmetric, audio-
grams of left ears were not shown). Tympanometry
showed a normal static compliance and normal
middle ear pressures.
Fourteen frequent ARNSHI loci among non-
Caucasians (11) were ruled out as the underlying
cause of HI in the family IR-Sh10. After this
Fig. 2. Pure-tone audiograms for all four affected individuals
from the family IR-Sh10 for the right ear.
exclusion, a genome wide linkage scan was carried
out. Significant linkage was found on chromosome
11q12.3–11q13.3 with a maximum multi-point
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Fig. 3. Idiogram of chromosome 11q, showing the DFNB93 chromosomal map location in relation to adjacent known DFNB loci.
Some STRP and SNP markers and some of the stronger candidate genes are shown. The three sequenced genes are underlined.
Physical map distances (Mb) are from the UCSC Genome Bioinformatics Build 37.1. Markers D11S1765 (60.68 Mb) and D11S1975
(70.30 Mb) define the DFNB93 critical interval region. Filled circles represent STRP and SNP markers (not drawn to scale).
LOD score of 3.4 between SNPs rs1783811
(64.33 Mb) and rs1671063 (66.27 Mb). A few
STRP microsatellite markers, selected from the
Decode (12) and LDB (13) genetic maps in the
interval were genotyped to confirm and refine
the linked region. Thirty-two markers in the
DFNB93 interval were genetically informative
for this family and thus were included for the
LOD score calculation. The candidate region
is delimited by markers D11S1765 (60.68 Mb)
and D11S1975 (70.30 Mb), with a maximum
multi-point LOD score of 3.5 for the region
between D11S1337 (68.03 Mb) and D11S4136
(69.51 Mb). The proximal recombination in the
maternal chromosome at marker D11S4155 could
be seen in two normal individuals, 1045 and 1046.
The pedigree, linked haplotype and a genetic map
of the linkage interval is shown in Fig. 1.
Five loci for ARNSHI have already been
mapped to chromosome 11q, including DFNB2
(MYO7A), DFNB20 (no gene identification yet),
DFNB21 (TECTA), DFNB24 (RDX ) and DFNB63
(LRTOMT ). Figure 3 illustrates the relative phys-
ical position of the DFNB93 locus and the neigh-
boring known HI loci and genes.
Analysis of the DFNB93 interval at 11q12.3–
11q13.3 revealed more than 300 annotated and
hypothetical genes in an approximately 9.62 Mb
region. Several of these genes are expressed in
the human or mouse inner ear (8, 9). Three
genes with strong relevance to HI were selected
for DNA sequencing including: CFL1 (14, 15),
KCNK4 (16) and RELA (17). However, no patho-
genic variant was identified in any of these
three genes. Even though LRTOMT is not within
the candidate region (exclusion by LOD score
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<− 2) and the audiometric profile of the family
IR-Sh10 is very different from LRTOMT fami-
lies who segregate severe-to-profound ARNSHI
(18–21), LRTOMT was also sequenced. How-
ever, no mutation was identified. Currently, we
are considering other candidate genes within
the interval. SLC22A11, SLC22A12, SLC22A20,
KCNK7, CABP4 and TPCN2 are among the
stronger candidate genes for DFNB93 locus.
Although the candidate region is <10.0 Mb, and
we have sequenced the coding region of the most
obvious candidate genes, we have not been able
to identify the disease-causing gene. This is not
unusual though, as there are many gene localiza-
tions for deafness in a similar situation. However,
the application of next generation sequencing may
be a good strategy for further analysis, leading to
the identification of many of these genes.
Although most ARNSHI families have profound
HI, the family IR-Sh10 presents a phenotype
of moderate-to-severe HI across all frequencies,
slightly more pronounced in the mid-frequencies.
A similar pattern has been previously reported for
the TECTA gene (2, 3, 22). The distinguishable
phenotype in families with ARNSHI caused by
a mutation in TECTA has led to the suggestion
that mutation analysis of TECTA should be offered
to ARNSHI families with such an audiometric
profile (2, 3, 23–27). The audiometric profile of
the family IR-Sh10 also provides a distinctive
clinical feature that may point toward this gene
for DNA diagnosis.
In summary, we have identified a novel ARN-
SHI locus at 11q12.3–11q13.2. It is the second
locus for the ARNSHI with a distinctive audio-
metric profile of moderate-to-severe HI. This rep-
resents a step forward toward the possibility to
predict the genetic cause based on the audiomet-
ric profile and is therefore of importance for DNA
diagnostics.
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